Suppr超能文献

熊果酸通过 ATM 介导的 DNA 损伤反应抑制 RKO 结直肠癌细胞的增殖和迁移。

Usnic Acid Inhibits Proliferation and Migration through ATM Mediated DNA Damage Response in RKO Colorectal Cancer Cell.

机构信息

Department of Biochemistry and Molecular Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, China.

Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.

出版信息

Curr Pharm Biotechnol. 2021;22(8):1129-1138. doi: 10.2174/1389201021666201002155955.

Abstract

BACKGROUND

Usnic Acid (UA), also known as lichenol, has been reported to have inhibitory effects on a variety of cancer cells, but its specific mechanism remained to be elucidated. Tumor chemotherapy drugs, especially DNA damage chemotherapeutic drugs, target Chromosomal DNA, but their spontaneous and acquired drug resistance are also an urgent problem to be solved. Therefore, drug combination research has become the focus of researchers.

METHODS

Here, we evaluated the tumor-suppressing molecular mechanism of UA in colorectal cancer cells RKO from the perspective of the ATM-mediated DNA damage signaling pathway through H2O2 simulating DNA damage chemotherapeutic drugs. CCK8 cell proliferation assay was used to determine the inhibition of RKO cells by hydrogen peroxide and UA alone or in combination, and wound healing assay was applied to determine the effect of the drug on cell migration.

RESULTS

Transfected cells with miRNA18a-5p mimics and inhibitors, MDC and DCFH-DA staining for the measurement of autophagy and ROS, cell cycle and apoptosis were detected by flow cytometry, expressions of microRNA and mRNA were determined by fluorescence quantitative PCR, and protein by Western blot.

DISCUSSION

We found that UA can upregulate ATM via miR-18a to activate the DNA damage signaling pathway and inhibit the proliferation and migration of RKO cells in a concentration-dependent manner.

CONCLUSION

At the same time, DNA damage responses, including cell cycle, autophagy, apoptosis and ROS levels, are also regulated by UA. Therefore, UA combined with DNA damage chemotherapeutic drugs may be an effective treatment for cancer.

摘要

背景

己酸(UA),又称地衣酚,据报道对多种癌细胞具有抑制作用,但具体机制尚不清楚。肿瘤化疗药物,尤其是 DNA 损伤化疗药物,以染色体 DNA 为靶点,但它们的自发性和获得性耐药性也是亟待解决的问题。因此,药物联合研究已成为研究人员关注的焦点。

方法

在这里,我们通过 H2O2 模拟 DNA 损伤化疗药物,从 ATM 介导的 DNA 损伤信号通路的角度评估 UA 在结直肠癌细胞 RKO 中的抑瘤分子机制。CCK8 细胞增殖实验用于测定过氧化氢和 UA 单独或联合对 RKO 细胞的抑制作用,划痕愈合实验用于测定药物对细胞迁移的影响。

结果

转染 miRNA18a-5p 模拟物和抑制剂的细胞,用 MDC 和 DCFH-DA 染色测量自噬和 ROS,用流式细胞术检测细胞周期和凋亡,用荧光定量 PCR 检测微 RNA 和 mRNA 的表达,用 Western blot 检测蛋白。

讨论

我们发现 UA 可以通过 miR-18a 上调 ATM,激活 DNA 损伤信号通路,以浓度依赖的方式抑制 RKO 细胞的增殖和迁移。

结论

同时,UA 还调节 DNA 损伤反应,包括细胞周期、自噬、细胞凋亡和 ROS 水平。因此,UA 联合 DNA 损伤化疗药物可能是癌症的有效治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验